19-57356047-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_020657.4(ZNF304):c.178G>A(p.Glu60Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000687 in 1,455,176 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_020657.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF304 | NM_020657.4 | c.178G>A | p.Glu60Lys | missense_variant | 3/3 | ENST00000282286.6 | NP_065708.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF304 | ENST00000282286.6 | c.178G>A | p.Glu60Lys | missense_variant | 3/3 | 2 | NM_020657.4 | ENSP00000282286.4 | ||
ZNF304 | ENST00000443917.6 | c.319G>A | p.Glu107Lys | missense_variant | 4/4 | 1 | ENSP00000401642.2 | |||
ZNF304 | ENST00000598744.1 | c.52G>A | p.Glu18Lys | missense_variant | 4/4 | 1 | ENSP00000470319.1 | |||
ZNF304 | ENST00000391705.7 | c.178G>A | p.Glu60Lys | missense_variant | 4/4 | 5 | ENSP00000375586.3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.87e-7 AC: 1AN: 1455176Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 722810
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 26, 2024 | The c.178G>A (p.E60K) alteration is located in exon 3 (coding exon 3) of the ZNF304 gene. This alteration results from a G to A substitution at nucleotide position 178, causing the glutamic acid (E) at amino acid position 60 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.